BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Ko HH, Cheng SL, Lee JJ, Chen HM, Kuo MY, Cheng SJ. Expression of AKR1B10 as an independent marker for poor prognosis in human oral squamous cell carcinoma. Head Neck 2017;39:1327-32. [PMID: 28301069 DOI: 10.1002/hed.24759] [Cited by in Crossref: 12] [Cited by in F6Publishing: 13] [Article Influence: 2.4] [Reference Citation Analysis]
Number Citing Articles
1 Cong Z, Diao Y, Xu Y, Li X, Jiang Z, Shao C, Ji S, Shen Y, De W, Qiang Y. Long non-coding RNA linc00665 promotes lung adenocarcinoma progression and functions as ceRNA to regulate AKR1B10-ERK signaling by sponging miR-98. Cell Death Dis 2019;10:84. [PMID: 30692511 DOI: 10.1038/s41419-019-1361-3] [Cited by in Crossref: 55] [Cited by in F6Publishing: 59] [Article Influence: 18.3] [Reference Citation Analysis]
2 Budach V, Tinhofer I. Novel prognostic clinical factors and biomarkers for outcome prediction in head and neck cancer: a systematic review. The Lancet Oncology 2019;20:e313-26. [DOI: 10.1016/s1470-2045(19)30177-9] [Cited by in Crossref: 54] [Cited by in F6Publishing: 28] [Article Influence: 18.0] [Reference Citation Analysis]
3 Ko HH, Peng HH, Cheng SJ, Kuo MY. Increased salivary AKR1B10 level: Association with progression and poor prognosis of oral squamous cell carcinoma. Head Neck 2018;40:2642-7. [PMID: 30430672 DOI: 10.1002/hed.25370] [Cited by in Crossref: 5] [Cited by in F6Publishing: 5] [Article Influence: 1.3] [Reference Citation Analysis]
4 Fang CY, Lin YH, Chen CL. Overexpression of AKR1B10 predicts tumor recurrence and short survival in oral squamous cell carcinoma patients. J Oral Pathol Med 2019;48:712-9. [PMID: 31237374 DOI: 10.1111/jop.12891] [Cited by in Crossref: 4] [Cited by in F6Publishing: 7] [Article Influence: 1.3] [Reference Citation Analysis]
5 Xu W, Gao Y, Zhang J, Zhang R, Chen Q. AKR1B10 expression in benign prostatic hyperplasia and its related mechanism. Oncol Lett 2021;22:683. [PMID: 34434282 DOI: 10.3892/ol.2021.12944] [Reference Citation Analysis]
6 Yao Y, Wang X, Zhou D, Li H, Qian H, Zhang J, Jiang L, Wang B, Lin Q, Zhu X. Loss of AKR1B10 promotes colorectal cancer cells proliferation and migration via regulating FGF1-dependent pathway. Aging (Albany NY) 2020;12:13059-75. [PMID: 32615540 DOI: 10.18632/aging.103393] [Cited by in Crossref: 5] [Cited by in F6Publishing: 6] [Article Influence: 2.5] [Reference Citation Analysis]
7 Liu R, Zheng S, Yang CY, Yu Y, Peng S, Ge Q, Lin Q, Li Q, Shi W, Shao Y. Prognostic value of aldo-keto reductase family 1 member B10 (AKR1B10) in digestive system cancers: A meta-analysis. Medicine (Baltimore) 2021;100:e25454. [PMID: 33832153 DOI: 10.1097/MD.0000000000025454] [Reference Citation Analysis]
8 Endo S, Xia S, Suyama M, Morikawa Y, Oguri H, Hu D, Ao Y, Takahara S, Horino Y, Hayakawa Y, Watanabe Y, Gouda H, Hara A, Kuwata K, Toyooka N, Matsunaga T, Ikari A. Synthesis of Potent and Selective Inhibitors of Aldo-Keto Reductase 1B10 and Their Efficacy against Proliferation, Metastasis, and Cisplatin Resistance of Lung Cancer Cells. J Med Chem 2017;60:8441-55. [PMID: 28976752 DOI: 10.1021/acs.jmedchem.7b00830] [Cited by in Crossref: 10] [Cited by in F6Publishing: 10] [Article Influence: 2.0] [Reference Citation Analysis]
9 Dai GP, Wang LP, Wen YQ, Ren XQ, Zuo SG. Identification of key genes for predicting colorectal cancer prognosis by integrated bioinformatics analysis. Oncol Lett 2020;19:388-98. [PMID: 31897151 DOI: 10.3892/ol.2019.11068] [Cited by in Crossref: 4] [Cited by in F6Publishing: 9] [Article Influence: 1.3] [Reference Citation Analysis]
10 Mazzio E, Badisa R, Mack N, Cassim S, Zdralevic M, Pouyssegur J, Soliman KFA. Whole-transcriptome Analysis of Fully Viable Energy Efficient Glycolytic-null Cancer Cells Established by Double Genetic Knockout of Lactate Dehydrogenase A/B or Glucose-6-Phosphate Isomerase. Cancer Genomics Proteomics 2020;17:469-97. [PMID: 32859627 DOI: 10.21873/cgp.20205] [Cited by in Crossref: 1] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
11 Liu J, Ban H, Liu Y, Ni J. The expression and significance of AKR1B10 in laryngeal squamous cell carcinoma. Sci Rep 2021;11:18228. [PMID: 34521883 DOI: 10.1038/s41598-021-97648-y] [Reference Citation Analysis]
12 Endo S, Matsunaga T, Nishinaka T. The Role of AKR1B10 in Physiology and Pathophysiology. Metabolites 2021;11:332. [PMID: 34063865 DOI: 10.3390/metabo11060332] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
13 Hojnik M, Šuster NK, Smrkolj Š, Sisinger D, Grazio SF, Verdenik I, Rižner TL. AKR1B1 as a Prognostic Biomarker of High-Grade Serous Ovarian Cancer. Cancers (Basel) 2022;14:809. [PMID: 35159076 DOI: 10.3390/cancers14030809] [Reference Citation Analysis]
14 Hojnik M, Frković Grazio S, Verdenik I, Rižner TL. AKR1B1 and AKR1B10 as Prognostic Biomarkers of Endometrioid Endometrial Carcinomas. Cancers (Basel) 2021;13:3398. [PMID: 34298614 DOI: 10.3390/cancers13143398] [Reference Citation Analysis]